Current approach in biochemical techniques & Regenerative Drug
Controlling structural organization and signaling motif display of biomimetic matrices at the nanometer scale is of great importance to the functional design of tissue regenerating materials. We have genetically engineered M13 bacteriophage (phage), naturally occurring nanofiber-like viruses, to display a high density of cell-signaling peptides on their major coat proteins. Structural orientation of these phage building blocks can be achieved due to their long-rod shape and monodispersity, which lead them to self-assemble into directionally organized liquid crystalline-like materials. We showed that the constructed viral nanofiber scaffolds were able to support neural progenitor cell proliferation and differentiation as well as direct orientation of their growth in three dimensions.Suchfunctionalized and structurally aligned phage matrices offer promising opportunities for therapies that address challenging medical problems, such as nerve tissue regeneration after spinal cord injuries, or as in vitro model systems for studying complicated cell signaling environments.
Related Conference of Current approach in biochemical techniques & Regenerative Drug
Current approach in biochemical techniques & Regenerative Drug Conference Speakers
Recommended Sessions
- Advances in cellular and molecular biology
- Clinical Enzymology & Enzyme engineering
- Current approach in biochemical techniques & Regenerative Drug
- Enzyme discovery
- Biological Imaging, Bio mechanics & Bio molecular Engineering
- Computational Enzymology
- Enzyme engineering and recombinant enzyme technology
- Enzymes in Food Technology
- Introduction to the CRISPR/Cas9 system and Genome Editing
- Macro molecular Biochemistry & Tissue Engineering
- Molecular Enzymology & Enzyme mechanisms
- Structural Biochemistry, Synthetic Biology & Tissue Engineering
Related Journals
Are you interested in
- Biochemistry - Glycobiology 2025 (Germany)
- Evolution of Glycan Diversity - Glycobiology 2025 (Germany)
- Genomics and Metabolomics - Glycobiology 2025 (Germany)
- Glycans in Diseases and Therapeutics - Glycobiology 2025 (Germany)
- Glycans in Drug Design - Glycobiology 2025 (Germany)
- Glycan’s - Glycobiology 2025 (Germany)
- Glycobiology - Glycobiology 2025 (Germany)
- Glycochemistry - Glycobiology 2025 (Germany)
- Glycoimmunology - Glycobiology 2025 (Germany)
- Glycoinformatics - Glycobiology 2025 (Germany)
- Glycolipids and Glycopeptides - Glycobiology 2025 (Germany)
- Glyconeurobiology - Glycobiology 2025 (Germany)
- Glycopathology - Glycobiology 2025 (Germany)
- Glycosience - Glycobiology 2025 (Germany)
- Proteoglycan and Sialic acid - Glycobiology 2025 (Germany)
- Recent Advances in Glycobiology - Glycobiology 2025 (Germany)
- Synthesis and Biological Role of Glycans - Glycobiology 2025 (Germany)